Negotiating AI-Life Sciences Partnerships To Minimize IP Risk
AI is a source of excitement and concern for stakeholders in the health care and life sciences industries. AI-enabled solutions are maturing and transforming various areas in these industries — such...To view the full article, register now.
Already a subscriber? Click here to view full article